Mycobacterium chelonae: Nonhealing leg ulcers treated successfully with an oral antibiotic

Journal of the American Board of Family Practice

Volumn 14, Issue 6, 2001, Pages 457-461

  Terry, Shawn ^a   Timothy, Nigel H ^a   Zurlo, John J ^b   Manders, Ernest K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CLINICAL FEATURE; DEBRIDEMENT; FEMALE; HUMAN; LEG ULCER; MEDICAL LITERATURE; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; TREATMENT OUTCOME; ULCER HEALING;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; FEMALE; HUMANS; LEG ULCER; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; TREATMENT OUTCOME;

EID: 0035197551     PISSN: 08938652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fenske NA, Millns JL. Resistant cutaneous infection caused by Mycobacterium chelonei. Arch Dermatol 1981;117:151-3.
2. Franck N, Cabie A, Villette B, Amor B, Lessana-Leibowitch M, Escande JP. Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin. J Am Acad Dermatol 1993;28:1019-21.
3. Woods GL, Washington JA 2nd. Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis 1987; 9:275-94.
4. Levine N, Rothschild JG. Treatment of Mycobacterium chelonae infection with controlled localized heating. J Am Acad Dermatol 1991;24(5 Pt 2): 867-70.
5. Smego RA Jr, Castiglia M, Asperilla MO. Lymphocutaneous syndrome. A review of non-sporothrix causes. Medicine (Baltimore) 1999;78:38-63.
6. Madjar DD Jr, Carvallo E, Proper SA, Fenske NA. Adjunctive surgical management of cutaneous Mycobacterium fortuitum infection. J Dermatol Surg Oncol 1985;11:708-12.
7. Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992;166:405-12.
8. Wilson S, Cascio B, Neitzschman HR. Radiology case of the month. Nail puncture wound to the foot. Mycobacterium chelonei osteomyelitis. J La State Med Soc 1999;151:251-2.
9. Thordarson DB, Patzakis MJ, Holtom P, Sherman R. Salvage of the septic ankle with concomitant tibial osteomyelitis. Foot Ankle Int 1997;18:151-6.
10. Jongevos SF, Prens EP, Habets JM. Successful triple-antibiotic therapy for cutaneous infection due to Mycobacterium chelonae. Clin Infect Dis 1999;28: 145-6.
11. Gremillion DH, Mursch SB, Lerner CJ. Injection site abscesses caused by Mycobacterium chelonei. Infect Control 1983;4:25-8.
12. Borghans JG, Stanford JL. Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine. Am Rev Respir Dis 1973;107: 1-8.
13. Foster MT, Sanders WE. Atypical mycobacterial infections complicating mammary implants. Atlanta, American Society for Microbiology, 1978.
14. Safranek TJ, Jarvis WR, Carson LA, et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 1987;317:197-201.
15. Plaus WJ, Hermann G. The surgical management of superficial infections caused by atypical mycobacteria. Surgery 1991;110:99-103.
16. Rappaport W, Dunnington G, Norton L, et al. The surgical management of atypical mycobacterial soft-tissue infections. Surgery 1990;108:36-39.
17. Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ 3rd. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992;36: 180-4.
18. Tartaglione T. Treatment of nontuberculous mycobacterium infections: role of clarithromycin and azithromycin. Clin Ther 1997;19:626-38.
19. Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis 1985;152:500-14.
20. Wallace RJ Jr, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993;119:482-6.
21. Saluja A, Peters NT, Lowe L, Johnson TM. A surgical wound infection due to Mycobacterium chelonae successfully treated with clarithromycin. Dermatol Surg 1997;23:539-43.
22. Driscoll M, Tyring SK. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. J Am Acad Dermatol 1997;36(3 Pt 1):495-6.
23. Wallace RJ Jr, Meier A, Brown BA, et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 1996;40:1676-81.